Nov 2 (Reuters) - Advisers to the U.S. Centers for Disease Control and Prevention on Tuesday voted unanimously to recommend the use of the Pfizer Inc and BioNTech SE COVID-19 vaccine for children aged five to 11 years.

The two-dose vaccine's rollout for the age group is set to begin as soon as CDC director Rochelle Walensky signs off on the recommendations made by the advisory panel.

(Reporting by Manojna Maddipatla in Bengaluru Editing by Chris Reese)